Evidence map›Paper›PMID 36297813›Full record

ArticlePlants (Basel, Switzerland)2022

Herniarin, Dimethylfraxetin and Extracts from

Sandra Liliana Porras-Dávila, Enrique Jiménez-Ferrer, Rubén Román Ramos, Manasés González-Cortazar, Julio César Almanza-Pérez, Maribel Herrera-Ruiz

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Phytochemicals fromPharmaceuticals (Basel, Switzerland) · 2024
    Article
  2. Effects of Five Coumarins and Standardized Extracts fromPharmaceuticals (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sandra Liliana Porras-DávilaCentro de Investigación Biomédica del Sur, Instituto Mexicano Del Seguro Social, Argentina No. 1, Col. Centro, Xochitepec 62790, Morelos, Mexico.ORCID 0000-0002-7709-4258
Enrique Jiménez-FerrerCentro de Investigación Biomédica del Sur, Instituto Mexicano Del Seguro Social, Argentina No. 1, Col. Centro, Xochitepec 62790, Morelos, Mexico.ORCID 0000-0002-0783-8274
Rubén Román RamosDoctorado en Ciencias Biológicas y de la Salud, División de Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana (UAM), Ciudad de México 04960, Mexico.
Manasés González-CortazarCentro de Investigación Biomédica del Sur, Instituto Mexicano Del Seguro Social, Argentina No. 1, Col. Centro, Xochitepec 62790, Morelos, Mexico.ORCID 0000-0002-3693-1670
Julio César Almanza-PérezDoctorado en Ciencias Biológicas y de la Salud, División de Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana (UAM), Ciudad de México 04960, Mexico.ORCID 0000-0002-9417-5500
Maribel Herrera-RuizCentro de Investigación Biomédica del Sur, Instituto Mexicano Del Seguro Social, Argentina No. 1, Col. Centro, Xochitepec 62790, Morelos, Mexico.ORCID 0000-0001-9056-3568
Mexican Social Security Institute · MXUniversidad Autónoma Metropolitana · MX

Funding

Fondo de Investigación en Salud INSTITUTO MEXICANO DEL SEGURO SOCIAL FIS/IMSS/PROT/PRIO/19/108 (R-2019-1702-005)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dimethylfraxetinhaloperidolherniarinketaminepsychosisTagetes lucida

Identifiers

PMID36297813
PMCPMC9610474
OpenAlexW4307269550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.